Micah N. Sagini

Riproximin Exhibits Diversity in Sugar Binding, and Modulates some Metastasis-Related Proteins with Lectin like Properties in Pancreatic Ductal Adenocarcinoma

A. Orry, M. Berger, K. Klika, 2020, Frontiers in Pharmacology.

Ethno medicinal, phytochemical and pharmacological aspects of solanum incanum (lin.)

H. Kariuki, J. Ngeranwa, J. Mwonjoria, 2014 .

Riproximin is a recently discovered type II ribosome inactivating protein with potential for treating cancer.

H. Adwan, M. Berger, Asim Pervaiz, 2014, Biotechnology advances.

The expression of genes contributing to pancreatic adenocarcinoma progression is influenced by the respective environment

R. Harbottle, M. Berger, F. Bergmann, 2018, Genes & cancer.

A subgroup of Lactosyl-Sepharose binding proteins requires calcium for affinity and galactose for anti-proliferation.

A. Hotz-Wagenblatt, M. Berger, Micah N. Sagini, 2020, Chemico-biological interactions.

Highlight article: Lactosyl-sepharose binding proteins from pancreatic cancer cells show differential expression in primary and metastatic organs

A. Hotz-Wagenblatt, M. Berger, K. Klika, 2020, Experimental biology and medicine.

Khasianine Affects the Expression of Sugar-Sensitive Proteins in Pancreatic Cancer Cells, Which Are Altered in Data from the Rat Model and Patients

R. Owen, M. Berger, K. Klika, 2023, ACS pharmacology & translational science.